Epidermal stem cells isolation struggle remains, mainly due to the yet essential requirement of well-de fi ned approaches and markers. The herein proposed methodology integrates an assemblage of strategies to accomplish the enrichment of the interfollicular epidermal stem cells multipotent fraction and their subsequent separation from the remaining primary human keratinocytes culture. Those include rapid adherence of freshly isolated human keratinocytes to collagen type IV through the β 1-integrin ligand and RhoAssociated Protein Kinase Inhibitor Y-27632 administration to the cultures, followed by an immunomagnetic separation to obtain populations based in the combined CD49f bri /CD71 dim expression. Flow cytometry is the supporting method to analyze the effect of the treatments over the expression rate of early epidermal markers keratins19/5/14 and in correlation to CD49f bri /CD71 dim subpopulations. The stepby-step methodology herein described indulges the boosting and consecutive puri fi cation and separation of interfollicular epidermal stem cells from human keratinocytes cultures.
Human keratinocytes (hKC) have a limited lifespan in culture that constraints their proliferative capacity and consequently their clinical potential. The long-term function of the skin equivalents generated in a Regenerative Medicine context can be limited by the length of time needed to obtain epithelial sheets in vitro, during which patient is highly susceptible to infection, and also by extensive culture that may lead to terminal differentiation of the hKC to be grafted, thus compromising its success. Therefore, the use of epidermal stem cells (EpSCs) that play an important role in cellular regeneration, wound healing, and neoplasm formation ( 1 ) for this purpose enlarges the possibility of providing an alternative and clinically relevant active source of biological material.
Despite a wide effort among stem cells biologists community ( 2-6 ) , EpSCs isolation dif fi culty remains, mainly due to the insuf fi ciency of molecular markers that distinguish these cells from other proliferative cells within skin basal layer, highlighting the need for de fi ning approaches and a panel of markers to obtain speci fi c and well-characterized cell populations. P63 is abundantly expressed by holoclones and therefore recognized as being also present in EpSCs playing an important role in morphogenesis and in the expression pattern of the cultures ( 7 ) . It has been also proposed that EpSCs exhibit a characteristic keratin pro fi le that includes the typical K5 and K14 expression of the basal layer but not of K1/10 of the suprabasal layer cells. K19 appears also as an EpSCs-associated marker as it is expressed by cells present in the skin hair follicles bulge and in the deep epidermal rete ridges within thicker epidermis, being also expressed by a subpopulation of hKC in the human basal layer during proliferative lateral skin expansion ( 8 ) .
Interestingly, the molecules related with cell-substratum adhesion are naturally meaningful as potential EpSCs markers, supported by the hypothesis that EpSCs require strong adherence to the basement membrane to maintain their stem cell characteristics or their position in the stem cell niche. ( 9 ) . b 1-integrin was fi rstly identi fi ed in highly proliferating KC (holoclones) and was used to distinguish EpSCs and other basal cells ( 5 ) . However, subsequent studies revealed that the majority of the cells of the basal layer in the human epidermis, EpSCs, and transient amplifying cells exhibit the expression of beta 1 integrin ( 10 ) and other putative markers such as the combination of CD49f ( α 6-integrin) and CD71 (transferrin receptor) ( 5 , and α 6 dim expressing cells, the fi rst being those with the highest proliferation rate and capability of long-term epidermal renewal ( 11 ) , even at a limited dilution.
Despite the high importance of EpSCs, they constitute between 1% and 10% of the basal layer cells and, independently of the standardization of a characteristic panel of markers, boosting this population in culture through enrichment methods is a major demand. The involvement of Rho-Associated Protein Kinase (Rock) in tissue homeostasis, namely in the epidermis, is already recognized. Regardless of the unconsciousness of the exact timing of events, the key role that Rock plays in determining hKC fate was clearly demonstrated. By blocking Rock function, an inhibition of hKc terminal differentiation and an increase in cell proliferation was observed ( 12 ) . It has also been shown that Rock inhibitor (Rocki) leads to an increased number of hKC in primary cultures that can survive and grow forming healthy colonies, thus suggesting its effect in boosting the cells exhibiting stem cell behavior ( 13 ) yet retaining the ability to differentiate and to form a strati fi ed epithelium in adequate organotypic models ( 14 ) . The herein proposed methodology describes an assemblage of strategies to accomplish enrichment and further puri fi cation of the EpSCs multipotent fraction present in 
Reagents Setup
1. Remove the exceeding fat tissue from the dermis with scissors and scalpel.
Wash the skin samples with antibiotic/antimycotic solution (±20 s).
3. Cut skin into 0.5 cm 2 pieces.
Incubate skin pieces in dispase working solution (2.5 U/mL) overnight at 4°C in a 250 mL fl ask. After incubation place the skin samples on a Petri dish and peel off epidermis from dermis using two pairs of forceps. 
10.
Wash pellet with 5 mL of PBS.
11. Poor cells trough a 100 μ m pore size cell strainer into a 50 mL Falcon tube.
12. Centrifuge for 4 min at 290 × g .
13.
Resuspend cell pellet (hKC) in KSFM.
1. Coat tissue culture surface with collagen IV, by incubating 5 μ g/cm 2 at 37°C, for at least 1 h ( see Note 3 ).
Wash with PBS.
3. Plate 2 × 10 4 hKC/cm 2 in KSFM.
4. Change medium every 2-3 days and keep the culture until 80% con fl uent. 2. Change medium every 2-3 days; keep them in culture until 80% con fl uent.
1. Perform steps 1 and 2 described in section 3.2.1.
2. Proceed as described in section 3.2.2 . 
Methods

Isolation of Human Keratinocytes from Adult Skin
Combined Approach
An intermediate analysis of a fraction of the obtained cells after each treatment should be performed in order to assess the effect in the increased fraction of interest-EpSCs fraction. Therefore in this section a fl ow cytometry protocol using a combination of CD49f-APC and CD71-PE markers is described.
1. Harvest the adherent cells cultured under the described conditions with trypsin-EDTA.
2. Transfer cells to a 15 mL falcon tube and add labeling buffer up to 10 mL.
3. Centrifuge cell suspension at 200 × g for 5 min.
4. Count cells using a hemocytometer.
5. Discard supernatant and resuspend cell pellet to a concentration of 0.5-10 6 cells/mL in fresh labeling buffer.
6. Add 100 μ L of cell suspension to each fl ow cytometry tube ( see Note 7 ).
7. Add 4 μ L of CD71-PE and 2 μ L CD49f-APC antibodies; reserve one tube per condition without antibody as control.
8. Incubate 30 min at room temperature.
9. Wash by adding 2 mL of PBS per tube and centrifuge at 250 × g for 3 min.
10. Resuspend cell pellets in 500 μ L of acquisition buffer.
11. Acquire data in fl ow cytometer.
12. Analyze simultaneous expression of CD71 and CD49f (Fig. 1 ).
1. Wash CD71 coated beads by placing the tubes in a magnet for 1 min, discarding the supernatant and adding 1 mL of Dynabeads buffer 2, twice.
2. Incubate the cells harvested on Subheading 3.3 , step 1 and resuspended in Dynabeads buffer 2 with the washed CD71 beads for 30 min at 2-8°C with gentle tilting and rotation.
3. Place the tubes in a magnet for 2 min.
4. Transfer the supernatant containing the unbound cells to a fresh 15 mL Falcon tube (CD71 − cell fraction).
5. Count cells using a hemocytometer.
6. Plate 2 × 10 4 cells/cm 2 in new tissue culture vessels/ fl asks with the correspondent treatments (described in Subheading 3.2 ).
7. Culture cells until 80% con fl uent by changing medium 2-3 days.
Harvest CD71
− cells with trypsin-EDTA and resuspend them in Dynabeads buffer 2.
2. Wash CD49f coated beads by placing the tubes in a magnet for 1 min, discarding the supernatant and adding 1 mL of Dynabeads buffer 2, twice. The analysis of the expression of the early epidermal markers on the obtained cell fraction by fl ow cytometry is advisable to validate the success of the employed strategies. Thus, this section comprises the protocol for identifying the expression of the intracellular markers using Cytokeratin 19-AF488 and Cytokeratin 14-FITC, and Keratin 5, respectively by direct and indirect staining. 9. Wash by adding 2 mL of PBS, centrifuge at 250 × g for 5 min, and remove supernatant.
11. Acquire data in fl ow cytometer (Fig. 2 ) . 
Indirect Staining
